Colorectal cancer (CRC), the second leading cause of cancer-related deaths in the United States, is increasingly linked to ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
It's a triple threat that has health experts concerned. Dr. Timothy Yeatman, a physician-scientist who participated in the study, wasn't minced-mouthed. He stressed a pressing need to rethink ...
Such tumors are classified as “microsatellite instability-high,” or MSI-H. According to Dr. Tim Yeatman, associate director of translational research at Tampa General Hospital Cancer Institute ...